Below are the financial statements of SpringWorks Therapeutics, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | — | — | — |
| Product revenue, net | 172.04a | 5.45a | 0a |
| Other revenue | 19.55a | 0a | 0a |
| Total revenue | 191.59a | 5.45a | 0a |
| Operating expenses | — | — | — |
| Cost of product revenue | -12.55a | -0.42a | 0a |
| Selling, general and administrative | -256.65a | -197.55a | -134.55a |
| Research and development | -200.52a | -150.49a | -146.12a |
| Total operating expenses | -469.72a | -348.46a | -280.67a |
| Loss from operations | -278.13a | -343.01a | -280.67a |
| Interest and other income | — | — | — |
| Interest and other income, net | 26a | 22.95a | 6.15a |
| Total interest and other income | 26a | 22.95a | 6.15a |
| Equity method investment loss | -6a | -5.04a | -2.89a |
| Net loss | -258.13a | -325.1a | -277.42a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore SpringWorks Therapeutics’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.